European equities traded in the US as American depositary receipts were edging lower late Wednesday morning, declining 0.18% to 1,435.51 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and telecommunications operator Telefonica (TEF), which rose 1.2% and 0.9% respectively. They were followed by biopharmaceutical company Calliditas Therapeutics (CALT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which were up 0.7% and 0.4% respectively.
The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and telecommunications operator VEON (VEON), which fell 4.4% and 2.9% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company DBV Technologies (DBVT), which were down 2.3% and 1.6% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which advanced 8.1% and 2.6% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and cruise line operator Carnival (CUK), which increased 2.7% and 2.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and NuCana (NCNA), which dropped 4.7% and 1.9% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 3.4% and 1.2% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。